CWRU is an Ohio-based educational institution that offers undergraduate and postgraduate degree programs in disciplines such as arts and engineering for students.
$1.5M
Jul 13, 2024
-
$1.7M
Jun 12, 2024
-
$16.5M
Jun 14, 2022
-
SparingVision is a France-based genomic medicines company that develops and commercializes synergistic gene therapy for the treatment of inherited retinal diseases.
$52.5M
Oct 19, 2020
-
SparingVision is a France-based genomic medicines company that develops and commercializes synergistic gene therapy for the treatment of inherited retinal diseases.
$18.1M
Jul 27, 2017
-
Frequently Asked Questions about Foundation Fighting Blindness
What is Foundation Fighting Blindness investing in?
Foundation Fighting Blindness has invested in 6 companies including CWRU, Opus Genetics and Nacuity Pharmaceuticals
What company did Foundation Fighting Blindness invest in?
Foundation Fighting Blindness invested in a total 6 companies including CWRU, Opus Genetics and Nacuity Pharmaceuticals
What are the top 5 investments by Foundation Fighting Blindness?
The top companies in which Foundation Fighting Blindness invested are CWRU, Opus Genetics, Nacuity Pharmaceuticals, SparingVision and SparingVision
